Загрузка...
Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma
Gold glyconanoparticles loaded with the listeriolysin O peptide 91–99 (GNP-LLO(91-99)), a bacterial peptide with anti-metastatic properties, are vaccine delivery platforms facilitating immune cell targeting and increasing antigen loading. Here, we present proof of concept analyses for the considerat...
Сохранить в:
| Опубликовано в: : | Oncoimmunology |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343812/ https://ncbi.nlm.nih.gov/pubmed/30713801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1541534 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|